235 related articles for article (PubMed ID: 1092768)
1. Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine.
Germanier R; Füer E
J Infect Dis; 1975 May; 131(5):553-8. PubMed ID: 1092768
[TBL] [Abstract][Full Text] [Related]
2. Vaccination against typhoid fever with a live oral vaccine.
Germanier R
Dev Biol Stand; 1976; 33():85-8. PubMed ID: 782975
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of the attenuated oral vaccine strain "S. typhi" Ty 21a.
Germanier R; Fürer E
Dev Biol Stand; 1983; 53():3-7. PubMed ID: 6873472
[TBL] [Abstract][Full Text] [Related]
4. A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results.
Wahdan MH; Sérié C; Cerisier Y; Sallam S; Germanier R
J Infect Dis; 1982 Mar; 145(3):292-5. PubMed ID: 7037982
[TBL] [Abstract][Full Text] [Related]
5. Virulence and immunogenicity of galactose-resistant variants of Salmonella typhi Ty21a.
Saxena M; Percheson PB; Di Fabio JL
J Infect Dis; 1993 Aug; 168(2):522-3. PubMed ID: 8336003
[No Abstract] [Full Text] [Related]
6. Inefficacy of the commercial live oral Ty 21a vaccine in the prevention of typhoid fever.
Hirschel B; Wüthrich R; Somaini B; Steffen R
Eur J Clin Microbiol; 1985 Jun; 4(3):295-8. PubMed ID: 4018068
[TBL] [Abstract][Full Text] [Related]
7. IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine.
Tagliabue A; Villa L; De Magistris MT; Romano M; Silvestri S; Boraschi D; Nencioni L
J Immunol; 1986 Sep; 137(5):1504-10. PubMed ID: 3489034
[TBL] [Abstract][Full Text] [Related]
8. [Properties of 2 gal+ derivatives of the vaccine mutant gal E Ty21a strain of Salmonella typhi].
Silva-Salinas BA; Rodríguez-Aguayo L; Maldonado-Ballesteros A; Valenzuela-Montero ME; Seoane-Montecinos M
Bol Med Hosp Infant Mex; 1985 Apr; 42(4):234-9. PubMed ID: 4005022
[No Abstract] [Full Text] [Related]
9. A preliminary report on the immunological responses after oral vaccine (Ty 21a).
Sirianni MC; Turbessi G; Scarpati B; Russo G; Mascellino MT; Aiuti F
Boll Ist Sieroter Milan; 1984 Sep; 63(4):352-6. PubMed ID: 6394032
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine.
Gilman RH; Hornick RB; Woodard WE; DuPont HL; Snyder MJ; Levine MM; Libonati JP
J Infect Dis; 1977 Dec; 136(6):717-23. PubMed ID: 925379
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of the protective immunity against murine typhoid: persistence of Salmonella L forms in the liver after immunization with live-cell vaccines.
Kita E; Nishikawa F; Kamikaidou N; Oku D; Yasui K; Kashiba S
FEMS Microbiol Immunol; 1992 Oct; 5(4):191-9. PubMed ID: 1419117
[TBL] [Abstract][Full Text] [Related]
12. Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD.
Zhu C; Xiong K; Chen Z; Hu X; Li J; Wang Y; Rao X; Cong Y
Microbiol Immunol; 2015 Aug; 59(8):443-51. PubMed ID: 26084199
[TBL] [Abstract][Full Text] [Related]
13. Immunity in experimental salmonellosis. II. Basis for the avirulence and protective capacity of gal E mutants of Salmonella typhimurium.
Germanier R; Fürer E
Infect Immun; 1971 Dec; 4(6):663-73. PubMed ID: 4949507
[TBL] [Abstract][Full Text] [Related]
14. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
15. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice.
Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
[TBL] [Abstract][Full Text] [Related]
18. The rpoS mutant allele of Salmonella typhi Ty2 is identical to that of the live typhoid vaccine Ty21a.
Robbe-Saule V; Norel F
FEMS Microbiol Lett; 1999 Jan; 170(1):141-3. PubMed ID: 9919662
[TBL] [Abstract][Full Text] [Related]
19. Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model.
Negi VD; Singhamahapatra S; Chakravortty D
Vaccine; 2007 Jul; 25(29):5315-23. PubMed ID: 17574312
[TBL] [Abstract][Full Text] [Related]
20. Some galE mutants of Salmonella choleraesuis retain virulence.
Nnalue NA; Stocker BA
Infect Immun; 1986 Dec; 54(3):635-40. PubMed ID: 3781619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
